Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4412 USD | -3.01% |
|
-16.75% | -96.00% |
05-24 | Allarity Therapeutics, Inc. Concludes Its Phase 2 Clinical Trial | CI |
05-14 | Allarity Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- ALLR Stock
- News Allarity Therapeutics, Inc.
- MarketScreener Editorial Features